MGNX logo

MGNX
Macrogenics Inc

4,111
Mkt Cap
$270.14M
Volume
2M
52W High
$4.35
52W Low
$1.19
PE Ratio
-3.82
MGNX Fundamentals
Price
$4.25
Prev Close
$4.16
Open
$4.13
50D MA
$3.18
Beta
1.44
Avg. Volume
751,687.27
EPS (Annual)
-$1.18
P/B
12.74
Rev/Employee
$510,238.91
$18.53
Loading...
Loading...
News
all
press releases
MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates
MacroGenics (MGNX) delivered earnings and revenue surprises of -1.75% and +12.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
More News
News Placeholder
Wall Street’s Risk-On Frenzy Returns
Among the session’s standout movers were Quantum Computing, which blasted through more than $1 billion in trading volume after reporting massive revenue growth and expanding its quantum-photonics footprint. Meanwhile, speculative traders also rotated heavily into AI-linked names including Dreamland Limited and media turnaround story BuzzFeed, both of which are holding onto substantial gains throughout the session. $TGNT, $QUBT, $BZFD, $TDIC, $HTCO, $MGNX, $CNCK, $VSTS
24-7 Market News·5d ago
News Placeholder
Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising guidance. Other gainers include Buzzfeed, MacroGenics, & SI-Bone.read more...
Benzinga·6d ago
News Placeholder
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -32.48% and +1.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates
Haemonetics (HAE) delivered earnings and revenue surprises of +1.04% and +2.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·11d ago
News Placeholder
MacroGenics (MGNX) to Release Quarterly Earnings on Tuesday
MacroGenics (NASDAQ:MGNX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-macrogenics-inc-stock...
MarketBeat·12d ago
News Placeholder
Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know
MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·12d ago
News Placeholder
MacroGenics Expands Zynyz Royalty Deal With Sagard
(RTTNews) - MacroGenics, Inc. (MGNX) on Monday said it has entered into an expanded royalty purchase agreement with Sagard Healthcare Partners, under which it will receive funding in exchange for a...
Nasdaq News: Markets·14d ago
News Placeholder
MacroGenics, Inc. (NASDAQ:MGNX) Short Interest Down 22.5% in April
MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 2,928,196 shares, a decline of 22.5% from the March 31st total of 3,778,755 shares. Currently, 5.3% of the shares...
MarketBeat·18d ago
News Placeholder
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of "Hold" from Brokerages
MacroGenics, Inc. (NASDAQ:MGNX - Get Free Report) has received an average rating of "Hold" from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have iss...
MarketBeat·23d ago
<
1
2
...
>

Latest MGNX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.